
Philippines Department of Justice recommends charges against six Sanofi officials
pharmafile | March 1, 2019 | News story | Medical Communications | Philippines, Sanofi, dengue, dengvaxia, vaccines
The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over the death and injury of hundreds of children and adults relating to a dangerous dengue vaccine.
One hundred and eighteen people, including 115 children and 33 adults, died after receiving Sanofi’s dengue vaccine, Dengvaxia, in 2016 after the Philippines became one of the first countries to use the vaccine in a mass immunisation programme.
The programme was suspended in 2017 after Sanofi announced that the vaccine could make cases of dengue worse in some cases in which patients had had no previous exposure.
The Philippines Department of Justice said in a statement on Friday that it would recommend charges be filed in court for reckless imprudence resulting in homicide, due to what it said were procedural lapses in the implementation of a dengue immunization program in 2016.
The government body recommended charges be filed against six Sanofi officials and 14 current and former Philippines health officials.
Louis Goss
Related Content

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria
Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition
The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline
Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology …






